Within the past ten years, a flurry of new therapies that use digital technology and software to treat, manage and prevent a variety of ailments have emerged, adopting the general branding: Digital therapeutics (DTx). Written by Andrés Melendez, Katie Ceraso, Arijit Nukala, Nina Tedeschi, and Rohini Singh Digital therapeutics must…

Written by Andres Melendez, Jake Pearson, Katie Ceraso, Arijit Nukala An Overview of Sequencing DNA sequencing has been a topic of interest for decades and, in current times, has evolved into an invaluable tool in understanding biology and in creating technologies that have revolutionized healthcare. On a broad scale, DNA…

Detecting cancer recurrence as early as possible is integral to preventing disease progression to later and deadlier stages of cancer. However, are we employing tools reliable enough to make this detection, or are the flaws in our current practices being overlooked? …

In recent years there have been multiple trends impacting how people receive medical care including practice methods such as Concierge Medicine and Direct Corporate Care, as well as the movement towards value-based care. Written by Victoria Chen, Charlie Almoney, Omar Aly, and Gwyn Alexander. The healthcare system in the United…

Developments in life-sciences are increasingly contributing to creating a food production industry that is less prone to wide-spread pathogen outbreaks among consumer communities. Written by Alex Kernagis, Ronak Mahatme and Nina Tedeschi For years, the FDA has enforced environmental monitoring protocols for food manufacturers in order to prevent the spread…

Data collection is instrumental to business and healthcare growth but can be time-consuming and overwhelming. So how can AI be used to solve this issue and advance the biotech industry? Written by Michael Linguadoca. AI in the Biotech Industry Artificial intelligence (AI) has previously held the preconceived notion of being…

With the bladder cancer market projected to grow in the upcoming years, the development of new immunotherapies like STING Agonists allow for a breakthrough in the fight against bladder cancer. Written by Omar Aly, Sarah Bortel, Jakob Heinz, and Andrés Melendez. Bladder Cancer Overview Bladder cancer is the most expensive cancer per the…

Drug development has historically been a long, expensive, and difficult process. How will the use of artificial intelligence impact the future of this industry? Written by Charlie Almoney, Morgan Kofsky, Jake Pearson, and Jenny Zwerling In 2019, the total estimated cost to research and develop a novel prescription medicine was…

We know MRD detection is feasible and widely employed for hematological cancers… but what does the future hold for solid tumor MRD technologies? Written by Alex Kernagis, Rayna Saldanha, Claire Liddy and Bryan Kaplan. A New Frontier The niche space of minimal residual disease testing is quickly growing within the world of biotech…